Due to health issues, this site is no longer maintained and will be shut down shortly. |
Atossa Genetics Inc is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
$0.70 +0.02 (2.52%)
As of 03/24/2023 16:00:01 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.